UPDATE: Goldman Sachs Reinstates Amicus Therapeutics (FOLD) at Neutral
Tweet Send to a Friend
(Updated - April 13, 2022 6:37 AM EDT)
Goldman Sachs analyst Salveen Richter reinstates coverage on Amicus Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Salveen Richter reinstates coverage on Amicus Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
